NCT01524497

A Clinical Study of Trazodone Hydrochloride Prolonged-Release Tablets for Treatment of Depression

A Clinical Study on Efficacy And Safety of Trazodone Hydrochloride Prolonged-Release Tablets for Treatment of Depression A Multicenter, Randomized, Double-Blind, Parallel Controlled Study

• Status: Completed
• Phase: Phase 2 / Phase 3
• Study type: Interventional
• Enrollment: 382 (actual)
• Sponsor: Lee's Pharmaceutical Limited · Industry
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Not accepted

Summary

This is a multicenter, randomized, double-blind, parallel-group, placebo-controlled study to evaluate the efficacy and safety of trazodone hydrochloride prolonged-release tablets for treatment of depression in Chinese population.

Conditions

• Depression

Interventions

Type	Name	Description
DRUG	Trazodone	75mg tablet/150 mg tablet
DRUG	Placebo	Reference drug: trazodone hydrochloride prolonged-release tablet placebo (corresponding dummy drug of 75mg, 150mg active drug)

Timeline

• Start date: 2011-11-01
• Primary completion: 2013-08-01
• Completion: 2013-11-01
• First posted: 2012-02-02
• Last updated: 2014-10-16

Locations

1 site across 1 country: China